PYX Resources: Achieving volume and diversification milestones. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

Replacement: Transaction in Own Shares

11 Jul 2022 13:26

RNS Number : 0431S
Intl. Biotechnology Trust PLC
11 July 2022
 

 

The Company incorrectly announced on 7 July 2022 (RNS No 7600R) that following a market purchase of 7,200 of its own Ordinary shares of 25p each, it held 520,608 Ordinary shares in treasury. The correct number of shares held in treasury is 520,808.

All other details remain unchanged.

 

The full amended text is shown below.

11th July 2022

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

("IBT" or the "Company")

 

Correction: Transaction in own shares

The Company announces that on 7th July 2022 it made a market purchase of 7,200 of its own Ordinary shares of 25p each, representing 0.02% of the issued share capital (excluding treasury shares). The shares were bought at 692.22292p per share and the Company intends to hold these shares in treasury.

As a result of the above transaction the Ordinary shares in issue, shares held in treasury, and the Total Voting Rights of the Company are now as follows:

Number of Ordinary Shares in issue

41,383,817

Number of Ordinary Shares held in treasury

520,808

Number of Ordinary Shares in issue (excluding treasury shares)

40,863,009

 

 

 

For further information contact:

 

 

Company Secretary - Link Company Matters

 

Indu Shastri +44 (0)7936 045789

 

LEI: 213800N1QUJ744P76D11

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSGPUMGMUPPGPG

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.